Galantamine as an Adjunctive Treatment in Major Depression

A rating scale for depression

Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · see citing works

Untitled work

Raskind (2000) · doi:10.1212/wnl.54.12.2261 · Cited by 870 · see citing works

Galantamine

Scott, L. J., & Goa, K. L. (2000) · Drugs · doi:10.2165/00003495-200060050-00008 · Cited by 383 · see citing works

Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders

Sacco, K. A., Bannon, K. L., & George, T. P. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104047273 · Cited by 201 · see citing works

Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats

Semba, J., Mataki, C., Yamada, S., Nankai, M., & Toru, M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00477-0 · Cited by 140 · see citing works

A novel effect of nicotine on mood and sleep in major depression

Salín-Pascual, R. J., & Drucker-Colı́n, R. (1998) · Neuroreport · doi:10.1097/00001756-199801050-00012 · Cited by 106 · see citing works

Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders

Sacco, K. A., Bannon, K. L., & George, T. P. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800403 · Cited by 100 · see citing works

Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression

Ferguson, S. M., Brodkin, J. D., Kenneth Lloyd, G., & Menzaghi, F. (2000) · Psychopharmacology · doi:10.1007/s002130000531 · Cited by 85 · see citing works

Donepezil and related cholinesterase inhibitors as mood and behavioral controlling agents

Burt, T. (2000) · Current Psychiatry Reports · doi:10.1007/s11920-000-0005-7 · Cited by 37 · see citing works

What Role Does Depression Play on the Performance of the Ruff 2 and 7 Selective Attention Test?

Ruff, R. M. (1994) · Perceptual and Motor Skills · doi:10.2466/pms.1994.78.1.63 · Cited by 10 · see citing works

Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis

Walczak, Ł. J., & Herbet, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179290 · Cited by 351 · see citing works

Cognitive remission: a novel objective for the treatment of major depression?

Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252 · see citing works

Smoking, nicotine and neuropsychiatric disorders

Döme, P., Lazáry, J., Kalapos, M. P., & Rihmer, Z. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.013 · Cited by 215 · see citing works

Cognitive dysfunction in major depression and bipolar disorder: <scp>A</scp>ssessment and treatment options

MacQueen, G. M., & Memedovich, K. A. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12463 · Cited by 172 · see citing works

Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine

Ago, Y., Koda, K., Takuma, K., & Matsuda, T. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11r01cr · Cited by 116 · see citing works

Cognitive Effects of Pharmacotherapy for Major Depressive Disorder: A Systematic Review

Keefe, R. S. E., McClintock, S. M., Roth, R. M., Doraiswamy, P. M., Tiger, S., & Madhoo, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08609 · Cited by 107 · see citing works

Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives

Salagre, E., Solé, B., Tomioka, Y., Fernandes, B. S., Hidalgo-Mazzei, D., Garriga, M., Jimenez, E., Sanchez-Moreno, J., Vieta, E., & Grande, I. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.034 · Cited by 71 · see citing works

Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field

Miskowiak, K. W., Ott, C. V., Petersen, J. Z., & Kessing, L. V. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.09.641 · Cited by 69 · see citing works

Cognition as a target in major depression: new developments.

Solé, B., Jiménez, E., Martinez-Aran, A., & Vieta, E. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.12.004 · Cited by 68 · see citing works

Highly efficient, selective and sensitive molecular screening of acetylcholinesterase inhibitors of natural origin by solid-phase extraction-liquid chromatography/electrospray ionisation-octopole-orthogonal acceleration time-of-flight-mass spectrometry and novel thin-layer chromatography-based bioautography

Mroczek, T. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2009.01.061 · Cited by 64 · see citing works

A critical review of pharmacotherapy for major depressive disorder.

Dupuy, J. M., Ostacher, M. J., Huffman, J., Perlis, R. H., & Nierenberg, A. A. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000083 · Cited by 61 · see citing works

Management of Late-Life Depression

Nelson, J. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_170 · Cited by 34 · see citing works

Cholinesterase Inhibitor Adjunctive Therapy for Cognitive Impairment and Depressive Symptoms in Older Adults with Depression

McDermott, C. L., & Gray, S. L. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q445 · Cited by 23 · see citing works

Effects of vortioxetine on biomarkers associated with glutamatergic activity in an SSRI insensitive model of depression in female rats

Hlaváčová, N., Li, Y., Pehrson, A. L., Sánchez, C., Bermúdez, I., Csanova, A., Ježová, D., & Franklin, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.008 · Cited by 23 · see citing works

Simultaneous determination of galanthamine and lycorine in Lycoris radiata by a capillary electrophoresis with an electrochemiluminescence method

Wang, Y., Zhu, G., Li, X., & Hao, Z. (2014) · Journal of Separation Science · doi:10.1002/jssc.201400639 · Cited by 18 · see citing works

Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression

Gartlehner, G., Hansen, R. A., Morgan, L. C., Thaler, K. J., Lux, L. J., Noord, M. V., Mager, U., Gaynes, B. N., Thieda, P., Strobelberger, M., et al. (2011) · Cited by 8 · see citing works

Linking altered neuronal and synaptic properties to nicotinic receptor Alpha5 subunit gene dysfunction: a translational investigation in rat mPFC and human cortical layer 6

Yang, D., Qi, G., Delev, D., Maskos, U., & Feldmeyer, D. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03230-9 · Cited by 7 · see citing works

Central Nervous System Stimulants and Drugs that Suppress Appetite

Aagaard, L. (2014) · Side effects of drugs annual · doi:10.1016/b978-0-444-62635-6.00001-2 · Cited by 3 · see citing works

Evidence-based pharmacotherapy of major depressive disorder

Dupuy, J. M., Ostacher, M. J., Huffman, J. C., Perlis, R. H., & Nierenberg, A. A. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511910395.005 · Cited by 3 · see citing works

Electroencephalographic Effects of Galantamine in Major Depressive Disorder

Elgamal, S. A., MARRIOTT, M. J., & MacQUEEN, G. M. (2009) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0b013e3181a184e5 · Cited by 3 · see citing works

Contemporary approaches to correction of cognitive impairment in endogenous depression

Oleichik, I. V., Shishkovskaia, T. I., & Баранов, П. А. (2020) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2020-4-82-93 · Cited by 1 · see citing works

Linking Altered Neuronal and Synaptic Properties to Nicotinic Receptor Alpha5 Subunit Gene Dysfunction: A Translational Investigation in Rat mPFC and Human Cortical Layer 6Preprint

Yang, D., Qi, G., Delev, D., Maskos, U., & Feldmeyer, D. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.12.589167 · Cited by 1 · see citing works

Risk Factors of Mood Disorders (Depression and Anxiety) in Smoking Subjects: Reliability with the Age of Smoking Initiation and Inflammatory Processes

Frih, H. (2014) · Annual Research & Review in Biology · doi:10.9734/arrb/2014/8040

La dépression majeure diminue le taux d'abstinence tabagique

Fond, G. B. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique)

Sertraline and Escitalopram But Not Other Antidepressants Increase Acetylcholinesterase Activity Ex Vivo in the Rat Frontal Cortex

Dharwadkar, J., Nayak, A. R., Rao, B. S. S., & Srikumar, B. N. (2026) · Annals of Neurosciences · doi:10.1177/09727531261448654

Adjunctive Lamotrigine Treatment for Major Depression

MALTESE, T. M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1833 · Cited by 30 · see citing works

Adjuvant Galantamine for Cognitive Dysfunction in a Patient with Bipolar Disorder

Dias, V. V., Brissos, S., & Gorman, J. M. (2006) · Journal of Psychiatric Practice · doi:10.1097/00131746-200609000-00010 · Cited by 6 · see citing works

Galantamine treatment for AD warranted in Canada

(2001) · PharmacoEconomics & Outcomes News · doi:10.1007/bf03280641

Adjunctive galantamine's effect on functioning in schizophrenia: No clear benefit

Kennedy, A., Wood, A. E., & Tapp, A. M. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.01.454

Methylfolate as Adjunctive Treatment in Major Depression

Reynolds, E. H. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13010084 · Cited by 10 · see citing works